Bridgebio Pharma trades 3,558 contracts. BBIO will report earnings today after the market closes. The company has the following event: MDA Clinical and Scientific Conference between Jan 1, 2026 and Dec 31, 2026.
Bridgebio Pharma will report earnings after the market closes. View Calendar The market is expecting a ±8.9% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±1.1%. View Expected Move (Conf Call: Oct 29 4:30 PM)
Bridgebio Pharma has traded lower yet again today, last trading at 66.25. Since this spiral started on 10-Sep-2026, the stock has dropped -12.9% in total. BBIO has only had a trend this long one other time in the past year, starting on 20-Aug-2026 and lasting for 13 days. The last time it had a downward trend this long, the stock lost another -5.5% in the two weeks that followed. View Stock Chart
Bridgebio Pharma has traded lower yet again today, last trading at 74.72. Since this spiral started on 20-Aug-2026, the stock has dropped -11.0% in total. This is the longest downward trend in the last year for BBIO. View Stock Chart
Bridgebio Pharma has traded lower yet again today, last trading at 74.76. Since this spiral started on 20-Aug-2026, the stock has dropped -10.9% in total. This is the longest downward trend in the last year for BBIO. View Stock Chart
